Literature DB >> 19810781

Attention-deficit hyperactivity disorder (ADHD) treatment and sudden death.

Frank M C Besag1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19810781     DOI: 10.2165/11530340-000000000-00000

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  11 in total

1.  Acute myocardial infarction in a young male on methylphenidate, bupropion, and erythromycin.

Authors:  Anil K George; Arun R Kunwar; Ashish Awasthi
Journal:  J Child Adolesc Psychopharmacol       Date:  2005-08       Impact factor: 2.576

2.  Myocardial infarction in an adolescent taking Adderall.

Authors:  Pritesh J Gandhi; Gladys U Ezeala; Tuonglan T Luyen; Tran C Tu; Maichi T Tran
Journal:  Am J Health Syst Pharm       Date:  2005-07-15       Impact factor: 2.637

3.  ADHD drugs and cardiovascular risk.

Authors:  Thomas Anders; Steven Sharfstein
Journal:  N Engl J Med       Date:  2006-05-25       Impact factor: 91.245

4.  ADHD drugs and cardiovascular risk.

Authors:  Marsha D Rappley; John W Moore; Deborah Dokken
Journal:  N Engl J Med       Date:  2006-05-25       Impact factor: 91.245

Review 5.  Stimulants and sudden death: what is a physician to do?

Authors:  Timothy E Wilens; Jefferson B Prince; Thomas J Spencer; Joseph Biederman
Journal:  Pediatrics       Date:  2006-09       Impact factor: 7.124

6.  ADHD drugs and cardiovascular risk.

Authors:  Steven E Nissen
Journal:  N Engl J Med       Date:  2006-03-20       Impact factor: 91.245

7.  Does childhood treatment of ADHD with stimulant medication affect substance abuse in adulthood?

Authors:  Nora D Volkow; James M Swanson
Journal:  Am J Psychiatry       Date:  2008-05       Impact factor: 18.112

Review 8.  Depression in epilepsy: prevalence, clinical semiology, pathogenic mechanisms, and treatment.

Authors:  Andres M Kanner
Journal:  Biol Psychiatry       Date:  2003-08-01       Impact factor: 13.382

9.  Mortality associated with attention-deficit hyperactivity disorder (ADHD) drug treatment: a retrospective cohort study of children, adolescents and young adults using the general practice research database.

Authors:  Suzanne McCarthy; Noel Cranswick; Laura Potts; Eric Taylor; Ian C K Wong
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

Review 10.  Attention-deficit-hyperactivity disorder: an update.

Authors:  Julie A Dopheide; Steven R Pliszka
Journal:  Pharmacotherapy       Date:  2009-06       Impact factor: 4.705

View more
  2 in total

Review 1.  Cardiovascular effects of methylphenidate, amphetamines and atomoxetine in the treatment of attention-deficit hyperactivity disorder: an update.

Authors:  Gariba A H Awudu; Frank M C Besag
Journal:  Drug Saf       Date:  2014-09       Impact factor: 5.606

Review 2.  Cardiovascular effects of methylphenidate, amphetamines and atomoxetine in the treatment of attention-deficit hyperactivity disorder.

Authors:  Gary Stiefel; Frank M C Besag
Journal:  Drug Saf       Date:  2010-10-01       Impact factor: 5.606

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.